- Report
- May 2022
- 36 Pages
Global
From €2224EUR$2,500USD£1,927GBP
- Report
- May 2022
- 51 Pages
Global
From €2224EUR$2,500USD£1,927GBP
- Report
- January 2026
Global
From €3549EUR$3,990USD£3,076GBP
- Report
- January 2026
North America
From €3549EUR$3,990USD£3,076GBP
- Report
- January 2026
Europe
From €3549EUR$3,990USD£3,076GBP
- Report
- January 2026
North America
From €3549EUR$3,990USD£3,076GBP
- Report
- January 2026
Europe
From €3549EUR$3,990USD£3,076GBP
- Report
- January 2026
Middle East
From €3549EUR$3,990USD£3,076GBP
- Report
- January 2026
Asia Pacific
From €3549EUR$3,990USD£3,076GBP
- Report
- January 2026
United States
From €3549EUR$3,990USD£3,076GBP
- Report
- January 2026
United Kingdom
From €3549EUR$3,990USD£3,076GBP
- Report
- January 2026
China
From €3549EUR$3,990USD£3,076GBP
- Report
- January 2026
Europe
From €3549EUR$3,990USD£3,076GBP
- Report
- January 2026
United States
From €3549EUR$3,990USD£3,076GBP
- Report
- February 2024
- 91 Pages
Global
From €3500EUR$4,215USD£3,140GBP
- Report
- September 2023
- 101 Pages
Global
From €3500EUR$4,215USD£3,140GBP
- Report
- May 2022
- 96 Pages
Global
From €3500EUR$4,215USD£3,140GBP
- Report
- September 2025
- 85 Pages
Global
From €3500EUR$4,215USD£3,140GBP
- Report
- September 2025
- 87 Pages
Global
From €3500EUR$4,215USD£3,140GBP
- Report
- August 2025
- 116 Pages
Global
From €3500EUR$4,215USD£3,140GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more